Samsung Galaxy Watch Active2 Can Monitor Blood Pressure In South Korea

For those who need to regularly check their blood pressure or just want to know what it is, Samsung has announced that its Galaxy Watch Active2 smartwatch will soon be able to monitor it for users in South Korea.

The Samsung Health Monitor app has been cleared by South Korea’s Ministry of Food and Drug Safety (MFDS) as “a Software as a Medical Device (SaMD), making it a government-cleared, over-the-counter and cuffless blood pressure monitor application,” the company revealed in a news release.

When paired with advanced sensor technology on the Galaxy Watch Active2, the Samsung Health Monitor app enables you to easily and more conveniently measure and track your blood pressure.

“The Samsung Health Monitor app has the potential to help millions of people around the world who are affected by high blood pressure,” says Taejong Jay Yang, Corporate SVP and Head of Health Team, Mobile Communications Business at Samsung Electronics. “This is one of many examples of how Samsung is integrating its best-in-class hardware with the latest software innovations to innovate mobile experiences.”

The Galaxy Watch Active allows users to check their blood pressure using My BP Lab 2.0, “which leverages the Watch Active’s innovative optical sensor to provide you with richer, more accurate information about your health.” It must be noted, however, that the My BP Lab 2.0 is not a medical therapeutic or diagnostic device.

That said, the Galaxy Watch Active2 comes with more sensitive and accurate heart rate monitoring sensors that enable users to track their exercise, sleep, stress and get added healthcare insights that can help with improved wellbeing.

The Samsung Health Monitor app will be available on the Galaxy Watch Active2 within the third quarter and progressively expanding to upcoming Galaxy Watch devices.

XDA Developers states that the Samsung Health Monitor application has only been approved in South Korea, and it will likely take a while for the app to make its way to other countries. In the US, it most likely will have to be approved through the Food and Drug Administration.